Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price traded down 31.3% during trading on Thursday . The company traded as low as C$0.14 and last traded at C$0.17. 1,643,425 shares traded hands during mid-day trading, an increase of 198% from the average session volume of 550,572 shares. The stock had previously closed at C$0.24.
Voyageur Pharmaceuticals Stock Performance
The business’s 50 day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.07. The firm has a market capitalization of C$23.01 million, a PE ratio of -16.50 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- What is the Dow Jones Industrial Average (DJIA)?
- Kimberly-Clark: A Regal Opportunity in This Dividend King
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 5 Stocks With Above-Market Yields Just Raised Payments Further
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Arista Networks’ Stock Plunge: Buying Opportunity for Investors?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
